Early divergence of treatment response trajectories to adalimumab or its biosimilar in active ankylosing spondylitis: consensus clustering analysis of a randomized controlled trial. [PDF]
Zhong Z +7 more
europepmc +1 more source
Sex Differences in Disease Activity Measures in Axial Spondyloarthritis and Their Association with Concomitant Fibromyalgia: A Retrospective Cross-Sectional Analysis of a Saudi Cohort. [PDF]
Bedaiwi M +5 more
europepmc +1 more source
Predicting ankylosing spondylitis disease activity via patient-reported outcome measures: Building prediction models based on machine learning. [PDF]
Gong Y, Liu A, Zhuo L, Xu X, Liu H.
europepmc +1 more source
Psychosocial dimensions of pain in axial spondyloarthritis: Construct validity and responsiveness of the multidimensional pain inventory (MPI). [PDF]
Kiefer D +7 more
europepmc +1 more source
Comparer la proportion de répondeurs aux anti-TNF a déterminés par le BASDAI et l'ASDAS en fonction du syndrome inflammatoire biologique dans une population de patients traités par infliximab pour une spondyloarthrite axiale.
Brehier, Quentin
core
Efficacy of Ixekizumab in Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level: A Pooled Analysis of Phase III Trials. [PDF]
Sengupta R +13 more
europepmc +1 more source
Measurement properties of instruments assessing peripheral arthritis disease activity in spondyloarthritis: a systematic literature review. [PDF]
Capelusnik D +9 more
europepmc +1 more source
Fibromyalgia and Central Sensitization in Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis: A Systematic Review. [PDF]
Eltoum HA +5 more
europepmc +1 more source
Efficacy and safety of dual-targeted therapy with tofacitinib and TNF inhibitors in refractory spondyloarthritis: a case series from a tertiary care center. [PDF]
Agrawal A, Yadav SS, Balakrishnan C.
europepmc +1 more source
Challenges in diagnosing and monitoring radiographic and non-radiographic axial spondyloarthritis in daily clinical practice. [PDF]
Spoorenberg A +3 more
europepmc +1 more source

